ipamorelin igf-1 increase percentage Plasma GH levels versus time in swine following i.v. administration of CJC-1295 vs Ipamorelin vs Sermorelin

de Jong, D

Edited by Boris Zhivotovsky Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made

Phase 1-2 trial of the BRAF inhibitor dabrafenib (D) plus MEK inhibitor trametinib (T) in BRAF V600 mutant colorectal cancer (CRC): Updated efficacy and biomarker analysis 32(5s), 2014

Wang A-L, Wang J-P, Wang H, Chen Y-H, Zhao L, Wang L-S, et al